Cart
sales@molnova.com
Ivermectin B1a
CAS No. 71827-03-7
Ivermectin B1a ( —— )
Catalog No. M27454 CAS No. 71827-03-7
Ivermectin B1a is the major (80%) component of commercially available ivermectin and a derivative of Avermectin B1a.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 335 | Get Quote |
|
| 10MG | 494 | Get Quote |
|
| 25MG | 782 | Get Quote |
|
| 50MG | 1053 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIvermectin B1a
-
NoteResearch use only, not for human use.
-
Brief DescriptionIvermectin B1a is the major (80%) component of commercially available ivermectin and a derivative of Avermectin B1a.
-
DescriptionIvermectin B1a is the major (80%) component of commercially available ivermectin and a derivative of Avermectin B1a.(In Vitro):Ivermectin B1a(0.3 μg/ml) is inactive, whereas in the case of the minor component, ivermectin B1b(0.3 μg/ml) produces 100% mortality of snails.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorσ1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number71827-03-7
-
Formula Weight875.1
-
Molecular FormulaC48H74O14
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC[C@@H]([C@@H]1[C@@H](C)CC[C@]2(C[C@@H]3C[C@@H](C/C=C(C)/[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)/C=C/C=C6CO[C@H]7[C@]\6(O)[C@H](C(O3)=O)C=C(C)[C@H]7O)O2)O1)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lan Y, et al. Synthesis and biological evaluation of novel sigma-1 receptor antagonists based on pyrimidine scaffold as agents for treating neuropathic pain. J Med Chem. 2014 Dec 26;57(24):10404-23.
molnova catalog
related products
-
Anagyrine
Anagyrine, is the responsible teratogen from teratogenic lupins, can produce congenital deformities in calves typical of crooked calf disease.
-
Bis(2-chloroethyl)am...
Pharmaceutical Intermediates
-
Aminomalonic acid
Aminomalonic acid (Ama) was first detected in alkaline hydrolysates of proteins in 1984. Ama has been isolated from proteins of Escherichia coli and human atherosclerotic plaque. The presence of Ama has important biological implications because the malonic acid moiety potentially imparts calcium binding properties to protein.
